Canadian application, no grantCanada
Arylamino fused pyridines and pyrimidines
CA 2250241 A1 · Owner: Cain, Gary Avonn · Inventors: Arvanitis, Argyrios Georgios; Bakthavatchalam, Rajagopal; Beck, James Peter
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Corticotropin releasing factor (CRF) antagonists of formula (I) or formula (II): and their use in treating anxiety depression, and other psychiatric and neurological disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 25, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 25, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 25, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 25, 1997
GrantedNo grant recorded
Term endedMarch 25, 2017
Patent numberCA 2250241 A1
Classification (IPC)C07D487/04 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.